Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 9/20 | 0.39 |
| ▸ | P2RY4 | P51582 | 6/20 | 0.39 |
| ▸ | P2RY6 | Q15077 | 8/20 | 0.39 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.38 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.38 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.38 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.38 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17546719 | 1.00 | P2RY2 (0.39) | P2RY2P2RY4P2RY6DNPH1TAS1R3 | |
| SCHEMBL15258090 | 0.92 | P2RY2 (0.36) | P2RY2P2RY4P2RY6DNPH1TAS1R3 | |
| SCHEMBL15725392 | 0.92 | P2RY2 (0.36) | P2RY2P2RY4P2RY6DNPH1TAS1R3 | |
| SCHEMBL17792581 | 0.92 | P2RY2 (0.36) | P2RY2P2RY4P2RY6DNPH1TAS1R3 | |
| SCHEMBL16247696 | 0.92 | P2RY2 (0.36) | P2RY2P2RY4P2RY6DNPH1TAS1R3 | |
| SCHEMBL15494174 | 0.92 | P2RY2 (0.36) | P2RY2P2RY4P2RY6DNPH1TAS1R3 | |
| SCHEMBL18293150 | 0.92 | P2RY2 (0.36) | P2RY2P2RY4P2RY6DNPH1TAS1R3 | |
| SCHEMBL18081881 | 0.92 | P2RY2 (0.36) | P2RY2P2RY4P2RY6DNPH1TAS1R3 | |
| SCHEMBL15250722 | 0.92 | P2RY2 (0.36) | P2RY2P2RY4P2RY6DNPH1TAS1R3 | |
| SCHEMBL15765769 | 0.92 | IMPDH2 (0.36) | P2RY2P2RY4P2RY6DNPH1TAS1R3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8680069-B2 | Modified polynucleotides for the production of G-CSF | MODERNA THERAPEUTICS, INC. (US) | 2014-03-25 | — | — | US | disclosed |
| US-20130253043-A1 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF G-CSF | modeRNA Therapeutics (US) | 2013-09-26 | — | — | US | disclosed |